New Medicines, Novel Insights: Advancing rare disease drug development

Novel therapies for rare diseases offer hope for thousands of patients and their families. This interactive report presents insights from Parexel experts doing everything humanly possible to deliver on the promise of patient-focused drug development – and to bring more rare disease treatments to market, faster.

Explore the report

 

Return to Insights Center

Related Insights

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023

Blog

Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression

Apr 23, 2024

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Report

New Medicines, Novel Insights: Achieving patient-guided drug development

Oct 30, 2023

Article

Bringing clinical trials to patients with the decentralized model

Jan 8, 2021

Podcast

Decentrally Speaking | Episode 3: Integrating the Patient Voice into Decentralized Trials

Jul 28, 2022

Blog

Studying rare cancer patient populations using integrated genomic and real-world data

Aug 30, 2023

Article

Australia: The Regulatory and Reimbursement Environment

Aug 28, 2023

Article

Australia: Infrastructure and Innovations for Clinical Trials

Aug 28, 2023

Whitepaper

The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations

Mar 9, 2023

Playbook

Insights from the 2022 R&D Innovation Survey

Feb 17, 2023